Intrinsic Value of S&P & Nasdaq Contact Us

Emerson Electric Co. EMR NYSE

NYSE • Industrials • Industrial - Machinery • US • USD

SharesGrow Score
59/100
2/7 Pass
SharesGrow Intrinsic Value
$180.85
+25.1%
Analyst Price Target
$162.92
+12.7%

Emerson Electric Co. (EMR) is a Industrial - Machinery company in the Industrials sector, currently trading at $144.56. It has a SharesGrow Score of 59/100, indicating a above average investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of EMR = $180.85 (+25.1% from the current price, the stock appears undervalued). Analyst consensus target is EMR = $163 (+12.7% upside).

Valuation: EMR trades at a trailing Price-to-Earnings (P/E) of 34.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.4.

Financials: revenue is $18.0B, -1.5%/yr average growth. Net income is $2.3B, growing at +80.2%/yr. Net profit margin is 12.7% (healthy). Gross margin is 52.8% (+11.1 pp trend).

Balance sheet: total debt is $13.8B against $20.3B equity (Debt-to-Equity (D/E) ratio 0.68, moderate). Current ratio is 0.88 (tight liquidity). Debt-to-assets is 32.8%. Total assets: $42.0B.

Analyst outlook: 21 / 41 analysts rate EMR as buy (51%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 29/100 (Fail), Growth 58/100 (Partial), Past 100/100 (Pass), Health 33/100 (Fail), Moat 84/100 (Pass), Future 52/100 (Partial), Income 55/100 (Partial).

$162.92
▲ 12.7% Upside
Average Price Target
Based on 41 Wall Street analysts offering 12-month price targets for Emerson Electric Co., the average price target is $162.92, with a high forecast of $185.00, and a low forecast of $125.00.
Highest Price Target
$185.00
Average Price Target
$162.92
Lowest Price Target
$125.00

EMR SharesGrow Score Overview

59/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 29/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 84/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 55/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — EMR

VALUE Fail
29/100
EMR trades at a trailing Price-to-Earnings (P/E) of 34.9 (S&P 500 average ~25). Forward PEG 3.4 — overvalued. Trailing PEG 28.33. Analyst consensus target is $163, implying +12.8% from the current price $145. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
EMR: -1.5%/yr revenue is, +80.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
EMR: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Fail
33/100
Balance sheet EMR: Debt-to-Equity (D/E) ratio 0.68 (moderate), Current ratio is 0.88 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Pass
84/100
EMR: Gross margin is 52.8% (+11.1 pp trend), $81B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 84/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 21 / 41 analysts rate EMR as buy (51%). Analyst consensus target is $163 (+12.8% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
55/100
EMR: Net profit margin is 12.7%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range90.06-165.15
Volume1.72M
Avg Volume (30D)3.46M
Market Cap$81.29B
Beta (1Y)1.28
Dividend Yield$2.1650
Share Statistics
EPS (TTM)4.06
Shares Outstanding$566.7M
IPO Date1972-06-01
Employees73,000
CEOSurendralal Lanca Karsanbhai
Financial Highlights & Ratios
Revenue (TTM)$18.02B
Gross Profit$9.52B
EBITDA$4.86B
Net Income$2.29B
Operating Income$2.24B
Total Cash$1.54B
Total Debt$13.76B
Net Debt$12.22B
Total Assets$41.96B
Price / Earnings (P/E)35.6
Price / Sales (P/S)4.51
Analyst Forecast
1Y Price Target$168.00
Target High$185.00
Target Low$125.00
Upside+16.2%
Rating ConsensusBuy
Analysts Covering41
Buy 51% Hold 41% Sell 7%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS2910111044

Price Chart

EMR
Emerson Electric Co.  ·  NYSE
Industrials • Industrial - Machinery
90.06 52WK RANGE 165.15
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message